Reassessment of cefaclor breakpoints for Haemophilus influenzae

F M MacKenzie1, K E Milne, I M Gould

  • 1Medical Microbiology Department, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN Scotland, UK.

Insights

Standard methods overestimate cefaclor minimum inhibitory concentrations (MICs) for Haemophilus influenzae due to instability. Kill curves reveal accurate cefaclor MICs comparable to cefuroxime, suggesting improved susceptibility testing.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Standard methods for determining antibiotic susceptibility, such as NCCLS broth microdilution, may overestimate minimum inhibitory concentrations (MICs) for certain drugs.
  • In vitro chemical instability of cefaclor has been previously shown to affect MICs for Streptococcus pneumoniae.

Purpose of the Study:

  • To evaluate the accuracy of standard methods in determining cefaclor MICs for Haemophilus influenzae.
  • To compare cefaclor's efficacy against H. influenzae with cefuroxime using kill curve analysis.

Main Methods:

  • Determined standard NCCLS broth microdilution and E-Test MICs for eight H. influenzae isolates.
  • Utilized kill curves to define bacteriostatic MICs, accounting for cefaclor's chemical instability over six hours.

Main Results:

  • Standard NCCLS methods overestimated cefaclor MICs for H. influenzae due to in vitro chemical instability over 18-24 hours.
  • The mean cefaclor MIC by NCCLS was 3.0 mg/L, compared to 0.8 mg/L for cefuroxime.
  • Bacteriostatic MICs determined by kill curves were not significantly different between cefaclor and cefuroxime.

Conclusions:

  • Standard susceptibility testing methods can overestimate cefaclor MICs against H. influenzae.
  • Accurate cefaclor MICs, when accounting for instability, are comparable to cefuroxime, suggesting potential for effective treatment.
  • Kill curve analysis provides a more reliable assessment of cefaclor's bacteriostatic activity against H. influenzae.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause: